SRP team publishes letter to the editor

SRP team publishes letter to the editor, “Cost-effectiveness of 70-gene signature versus AdjuvantOnline and systemic chemotherapy for risk stratification of patients with node-negative breat cancer. Does accuracy matter?”

« Return